Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 1, 2008, Pages 115-122

  Chuanchuen, Rungtip ^a   Wannaprasat, Wechsiri ^a   Schweizer, Herbert P ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39649113106     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aendekerk S, Ghysels B, Cornells P, Baysse C. Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology 2002; 148: 2371-81.
2. Aires JR, KoehlerT, Nikaido H, Plesiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to amino-glycosides. Antimicrob Agents Chemother 1999; 43: 2624-8.
3. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001; 45: 428-32.
4. Chuanchuen R, Murata T, Gotoh N, Schweizer HP. Substrate-dependent utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK efflux pump. Antimicrob Agents Chemother 2005; 49: 2133-6.
5. Chuanchuen R, Narasaki CT, Schweizer HP. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol 2002; 184: 5036-44.
6. de Lorenzo V, Eltis L, Kessler B, Timmis KN. Analysis of Pseudomonas gene products using laclq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene 1993; 123: 17-24.
7. Hancock RE, Brinkman FS. Function of Pseudomonas porins in uptake and efflux. Annu Rev Microbiol 2002; 56: 17-38.
8. Hancock REW, Siehnel R, Martin N. Outer membrane proteins of Pseudomonas. Mol Microbiol 1990; 4: 1069-75.
9. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 1998; 212: 77-86.
10. Jo JT, Brinkman FS, Hancock RE. Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins. Antimicrob Agents Chemother 2003; 47: 1101-11.
11. Koehler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechere JC. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997; 23: 345-54.
12. Lomovskaya O, Warren MS, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
13. Masuda N, Sagagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000a; 44: 2242-46.
14. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Substrate specificities of MexAB-OprM, MexCD-OprJ and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000b; 44: 3322-27.
15. Miller JH. A short course in bacterial genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1992.
16. Murata T, Gotoh N, Nishino T. Characterization of outer membrane efflux proteins OpmE, OpmD and OpmB of Pseudomonas aeruginosa: molecular cloning and development of specific antisera. FEMS Microbiol Lett 2002; 217: 57-63.
17. NCCLS. Performance standards for antimicrobial susceptibility testing. Eight informational supplement. NCCLS Document M100-S8. PA, USA: NCCLS, 1998.
18. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 479-87.
19. Poole K, Gotoh N, Tsujimoto H, et al. Overexpression of the mexC-mexD-oprJ effux operon in nfxB-type multidrug resistant strains. Mol Microbiol 1996; 21: 713-24.
20. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993; 175: 7363-72.
21. Renau TE, Leger R, Flamme EM, et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 1999; 42: 4928-31.
22. rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
23. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003; 2: 48-62.
24. Vogne C, Aires JR, Bailly C, Hocquet D, Plesiat P. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chernother 2004; 48: 1676-80.
25. Watson JM, Holloway BW. Chromosome mapping in Pseudomonas aeruginosa. J Bacteriol 1978; 133: 1113-25.
26. Westbrock-Wadman S, Sherman DR, Mickey MJ, et al. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside resistance. Antimicrob Agents Chemother 1999; 43: 2975-83.
27. Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn Microbiol Infect Dis 2004; 50: 43-50.